Who is suitable for treatment with Ablatherm HIFU?

HIFU is a treatment option for patients with organ-confined prostate cancer with the advantages of:

1. Minimally invasive. No radiation. No wounds.
2. Repeatable and also allows the use of other therapeutic modalities post HIFU treatment if necessary (except radical surgery).

It can be considered as an option for:

• Patients with T1-T2 primary CaP.
• Patients who are not suitable for radical surgery due to age or co-morbidities.
• Patients who desire a minimally invasive, effective treatment option.
• Patients who have disease recurrence after radiotherapy.